Loading...
OTCM
GMVDF
Market cap254kUSD
Dec 05, Last price  
0.02USD
1D
0.00%
1Q
18,100.00%
IPO
-91.33%
Name

G Medical Innovations Holdings Ltd

Chart & Performance

D1W1MN
OTCM:GMVDF chart
P/E
P/S
0.06
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
269.07%
Revenues
4m
-12.61%
0109,0003,062,0005,525,9994,900,0005,058,0004,420,000
Net income
-14m
L-6.25%
0-27,247,000-16,976,000-15,506,000-12,688,000-14,888,000-13,958,000
CFO
-18m
L+60.77%
00-15,456,0000-4,647,000-11,494,000-18,479,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.
IPO date
Oct 26, 2017
Employees
84
Domiciled in
KY
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT